Quest Diagnostics, Inc. (NYSE: DGX) is -7.91% lower on its value in year-to-date trading and has touched a low of $119.59 and a high of $148.62 in the current 52-week trading range. The question becomes, what are the chances the stock will make a comeback and enjoy potential growth. Why not look at analysts view on what the future holds for the stock. The DGX stock was last observed hovering at around $127.42 in the last trading session, with the day’s loss setting it -0.44%.
Currently trading at $126.98, the stock is -2.62% and -0.92% below its SMA20 and SMA50 respectively. However, with a daily trading volume of 0.89 million and changing -0.35% at the moment leaves the stock -3.45% off its SMA200. DGX registered -11.26% loss for a year compared to 6-month gain of 3.40%.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
The stock witnessed a -0.91% loss in the last 1 month and extending the period to 3 months gives it a -5.04%, and is -3.53% down over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 1.64% over the week and 1.65% over the month.
Quest Diagnostics, Inc. (DGX) has around 48000 employees, a market worth around $14.06B and $9.25B in sales. Current P/E ratio is 16.96 and Fwd P/E is 13.51. Profit margin for the company is 9.19%. Distance from 52-week low is 6.18% and -14.56% from its 52-week high. The company has generated returns on investments over the last 12 months (7.58%).
The EPS is expected to grow by 0.44% this year
The shares outstanding are 111.00M, and float is at 109.71M with Short Float at 2.32%.
Quest Diagnostics, Inc. (DGX) Insider Activity
The most recent transaction is an insider sale by PREVOZNIK MICHAEL E, the company’s SVP & General Counsel. SEC filings show that PREVOZNIK MICHAEL E sold 5,611 shares of the company’s common stock on Feb 29 ’24 at a price of $125.88 per share for a total of $0.71 million. Following the sale, the insider now owns 38478.0 shares.
Quest Diagnostics, Inc. disclosed in a document filed with the SEC on Feb 29 ’24 that Doherty Catherine T. (EVP, Regional Businesses) sold a total of 1,187 shares of the company’s common stock. The trade occurred on Feb 29 ’24 and was made at $125.88 per share for $0.15 million. Following the transaction, the insider now directly holds 68412.0 shares of the DGX stock.
Still, SEC filings show that on Feb 28 ’24, Doherty Catherine T. (EVP, Regional Businesses) disposed off 5,557 shares at an average price of $126.57 for $0.7 million. The insider now directly holds 69,599 shares of Quest Diagnostics, Inc. (DGX).
